InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance

InMed Pharmaceuticals Inc. (NASDAQ: INM) announced it received a notice from Nasdaq regarding its failure to meet the minimum $1.00 bid price requirement for continued listing. The company’s common stock traded below this threshold for 30 consecutive trading days between February 11, 2026, and March 26, 2026. InMed has 180 calendar days to regain compliance, and its shares will continue to trade on The Nasdaq Capital Market under the symbol “INM” while it explores options to cure the deficiency.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin